I've seen my share of weird market groupings over the years, but this basket of ten companies feels exactly like a Wall Street garage sale. You dig through the pile and find a perfectly functional piece of enterprise infrastructure sitting right next to a broken crypto ATM. While the entire tech sector is hyperventilating over the next generation of AI chips, these periphery players show us the market's true dichotomy: some are doing the hard work, and others are just wasting our time. This is stupid and here's why.

The Ones Actually Doing the Work

I always have time for companies that ignore the Silicon Valley hype cycle and just solve actual problems. Tetra Tech (TTEK.US) is the perfect example. While tech bros are pitching AI to save the world, this engineering firm quietly pulled in USD 1.22 billion in revenue during Q2 2026, grabbing massive environmental monitoring contracts from the EPA and the Army Corps of Engineers. Upgrading your full-year earnings guidance in a boring infrastructure market? Now that is real business.

Liquidia (LQDA.US) in the biopharma space is another rare adult in the room. Too many biotech firms sell a ten-year fantasy, but Liquidia actually ships a product. Their inhaled powder YUTREPIA helped drive nearly USD 130 million in product sales in Q1 2026, earning them a spot in the S&P SmallCap 600. Execution matters.

Then we have Frequency Electronics (FEIM.US). Space is the new billionaire playground, and FEI is out here selling the atomic clocks and precision timing systems that make it all work. Their addressable market is expected to top USD 1 billion. Being the indispensable hardware guy in an expensive space race is a great place to be.

As for Cirrus Logic (CRUS.US), the audio chip veteran is sitting on roughly USD 1.8 billion in FY2024 revenue. John Forsyth has a solid foundation, but why aren't you moving faster into adjacent power and haptics markets? The mobile boom is long over, and resting on legacy tech is a dangerous game.

The Walking Dead

If the first group is doing real business, these next few players are pulling stunts that make me roll my eyes.

Take Bitcoin Depot (BTMWQ.US). A company operating Bitcoin ATMs actively filed for Chapter 11 bankruptcy in May 2026. They reported over USD 600 million in revenue for 2025 and still managed to go bust. In a world where Bitcoin ETFs are mainstream, the cash-to-crypto kiosk model is completely obsolete. Alex Holmes stepped in as CEO right before the music stopped. Good luck with that.

Then there's WORK Medical Technology (WOK.US) and its related ticker Worksport (WKSP.US). To avoid getting kicked off the Nasdaq, they executed a desperate 1-for-100 reverse stock split in June 2026. My experience says that is the universal death rattle of a public company. Sure, they recently announced a new AI-driven blood analyzer and are throwing around buzzwords like BioToken, but slapping AI on a medical device doesn't magically fix a broken cap table.

In the energy sector, Greenland Energy (GLND.US) is doubling down on Arctic oil drilling. It's 2026, and they are doing high-cost fossil fuel exploration while the planet burns? They raised USD 70 million and dragged Halliburton into this project, but it feels like a massive, risky bet against the arc of history.

The Phantoms

Finally, we have Archer-Daniels-Midland (ADM.US) and Trilogy Metals (TMQ.US). Both have been completely silent in this recent cycle. In a market where you either evolve rapidly or die, flying under the radar with zero meaningful updates usually means you are becoming irrelevant.

My view is clear: stop paying attention to the reverse-split artists and crypto disasters. Follow the companies with actual revenue that are quietly compounding value in the boring sectors.

This article does not constitute investment advice.